Can GlaxoSmithKline plc Help You To Retire Rich?

Dreaming of wealth in retirement? Here’s how GlaxoSmithKline plc (LON: GSK) could help you get there.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

GlaxoSmithKline

It’s been a very tough year for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Shares in the pharmaceutical company have fallen by 10% over the last year and have shown little sign of improving their performance in recent weeks.

However, the future could be much brighter for investors in the company. Indeed, GlaxoSmithKline could help you retire rich. Here’s how.

Income Prospects

With shares in GlaxoSmithKline currently yielding 5.8%, it is clear that they are a hugely attractive income play. However, they have the potential to deliver much higher levels of income over the long run. For example, GlaxoSmithKline is expected to increase dividends per share by 3.8% next year and, with an improving pipeline, this growth rate could increase at a brisk pace.

Pipeline Potential

On the subject of GlaxoSmithKline’s pipeline, investor attention has been drawn away from it in recent months as bribery allegations have taken centre stage. However, it remains hugely diverse and comes with a large amount of potential that could provide a boost to the company’s bottom line. This is even more so since the company became a pure play pharmaceutical following the sale of its consumer brands, which should allow it to add even more value via its pipeline moving forward.

Valuation

On the face of it, GlaxoSmithKline’s valuation doesn’t look all that appealing. For example, it has a price to earnings (P/E) ratio of 14.8, which is higher than the FTSE 100’s P/E ratio of 13. However, for a major pharmaceutical stock with a great pipeline, this seems cheap. After all, sector peer, Shire, was trading at over 20 times earnings when US rival AbbVie approached it with a takeover offer. Therefore, there still seems to be considerable potential for GlaxoSmithKline’s rating to move upwards over the medium to long term.

Looking Ahead

Certainly, bribery allegations have not helped to lift market sentiment and, even though GlaxoSmithKline has now been fined £300 million by Chinese authorities, many investors are still wary of taking a position in the company due to ongoing allegations elsewhere. So, while sentiment could remain weak in the short term, GlaxoSmithKline seems to have a bright long-term future, which is based around its pipeline potential. As a result, it could boost your bottom line and help you to retire rich.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing For Beginners

3 steps to protect my ISA as inflation starts to move higher

Jon Smith explains several ways that he can help his ISA investments to ride out a potential second wave of…

Read more »

Investing Articles

The IAG share price is up 93% in 2024! What next?

The share price of British Airways owner IAG has certainly gained altitude this year. Our writer thinks it could head…

Read more »

Investing Articles

Here’s how an investor might aim to turn £20,000 into £678 a month of tax-free passive income

Buying high-yield stocks within a Stocks and Shares ISA could produce a lovely passive income stream in time. Paul Summers…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

2 FTSE 100 dividend stocks I’m avoiding like the plague in January!

The potential benefits of owning these dividend stocks is outweighed by the risks, argues Royston Wild. Here's why he's buying…

Read more »

Happy African American Man Hugging New Car In Auto Dealership
Investing Articles

£20,000 invested in Tesla shares at the start of 2024 is now worth…

Backing the electric car maker at the beginning of 2024 would have been a great move. But will Tesla shares…

Read more »

US Stock

Nvidia stock jumped almost 200% this year. Here’s what could happen in 2025

Jon Smith explains why he feels Nvidia stock is unlikely to repeat the performance of 2024 and outlines where he's…

Read more »

Investing Articles

3 passive income mistakes I aim to avoid in 2025

When I consider the right way to invest for passive income in 2025, I think the key is to first…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Here’s a success story that shows how penny shares can deliver

What do we want penny shares to do? Grow to 100p and stop being penny shares. When do we want…

Read more »